Market Overview

JP Morgan Maintains MAP Pharmaceuticals at Overweight, Lowers PT from $23 to $22

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: JP MorganPrice Target Analyst Ratings

 

Related Articles (MAPP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional